Press Release • January 2026
DUBLIN, January 2026 – Nemysis Limited is pleased to announce its participation as a founding member of the European Healthcare Alliance (EHA), a newly established platform designed to streamline business development and licensing activities across the healthcare sector.
EHA is a membership-based organization aimed at showcasing products available for licensing from its member companies. The platform provides a fast and intuitive search tool, enabling companies to efficiently identify and access new business opportunities shared within the network.
In addition, EHA will expand its scope to support the identification of innovative products available for commercialization within the European market, further facilitating cross-border partnerships and market access.
Commenting on the initiative, Danilo Casadei Massari, Chairman & CEO of Nemysis Limited, stated:
“We are very pleased to participate in EHA, given its innovative approach to simplifying business development. It represents a valuable complement to our internal capabilities. The exchange of information on available products will provide new opportunities to expand our portfolio and strengthen collaborations with our existing commercial partners.”
Antonio Maggi, CEO of Enteralia Bioscience S.r.l., added:
“We are proud to be among the founders of EHA, a true innovation that will simplify and accelerate interactions among pharmaceutical companies seeking new and innovative business development opportunities.”
Pierfrancesco Maschio, CEO of Ricerchimica S.r.l., commented:
“We are pleased to be a founding member of the European Healthcare Alliance, as EHA strongly aligns with our core activities in M&A and licensing advisory within the Life Sciences sector. The platform represents a complementary tool to our transaction-focused approach, facilitating early identification and screening of licensing and acquisition opportunities, and enhancing connectivity among asset owners and potential partners across Europe. We believe EHA will further streamline deal origination and accelerate value creation for all stakeholders involved.”
About the European Healthcare Alliance (EHA)
Founded in 2026 by Nemysis Limited, Ricerchimica S.r.l., and Enteralia Bioscience S.r.l., EHA is an innovative platform designed to enhance business development activities across Europe. It provides member companies with a streamlined tool to showcase licensing opportunities, while also offering non-EU companies a one-stop access point to identify and connect with regional commercial partners across multiple European markets.
About Enteralia Bioscience
Enteralia Bioscience S.r.l., part of the Nemysis Limited Group, is an Italian pharmaceutical company focused on expanding direct commercial activities for the Group’s product portfolio. This strategic initiative enhances access to the value chain and reflects Nemysis’ evolution into a fully integrated biopharmaceutical company.
About Ricerchimica
Ricerchimica S.r.l. is a Life Sciences consulting firm specializing in M&A and transaction services, including licensing (in and out), asset acquisition and divestment, and business development support. Founded in 1973, the company has extensive experience in managing pharmaceutical transactions and supporting partners throughout the evaluation and deal-making process.
Source: Nemysis Limited, Ricerchimica, Enteralia Bioscience
www.eha-network.com
www.nemysisltd.com
www.enteralia.it
www.ricerchimica.com